Friday, July 31, 2015

Berwyn's QR Pharma gets $3 million from U.S. Army for traumatic brain injury study

Berwyn's QR Pharma gets $3 million from U.S. Army for traumatic brain injury study.

Berwyn's QR Pharma gets $3 million from U.S. Army for traumatic brain injury study


QR Pharma is a five-year-old start up based in Berwyn, but the young company has connected with well-known people and groups as it seeks funding to make drugs to treat Alzheimer's disease and Parkinson's disease.

In 2012, QR Pharma got $468,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to conduct research on compound called Posiphen as a potential treatment for Parkinson's. This grant is for work that will be led by Dr. Robert Nussbaum of the University of California, San Francisco and Jack T. Rogers, an associate professor of psychiatry at the genetics and aging research unit of Massachusetts General Hospital.

On Tuesday, QR Pharma said it it got $3 million from the U.S. Army to study Posiphen as a treatment for traumatic brain injury (TBI). This grant is to study the medication in two different trials in mice and it will be conducted in conjunction with the University of California Los Angeles. The UCLA doctors involved are Marie-Francoise Chesselet and David Hovda. Chesselet is chairwoman of the neurobiology department at the David Geffen School of Medicine at UCLA. Hovda has been honored by the Army for his work in developing ways to treat TBI.

The Defense and Veterans Brain Injury Center (link here) keeps track of service members receiving a medical diagnosis of traumatic brain injury anywhere U.S. forces are located, including the continental U.S. Perhaps surprisingly, more than 80 percent of traumatic brain injuries occur outside of war zones. Common causes of TBI include crashes in privately owned and military vehicles, falls, sports and recreation activities, and military training, according to the DVBIC web site.

The DVBIC began keeping track of TBIs in 2000. The worst year for TBI in the military was 2011, when 32,625 soldiers, sailors, airmen and Marines were diagnosed with TBI of all severities.

The 2012 total decreased and 2013 is on track for a still lower figure. That positive trend is at least partially attributable to U.S. forces withdrawing from Iraq completely by December of 2011 and beginning to withdraw from Afghanistan.



We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at

David Sell
Also on
letter icon Newsletter